You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gsk1349572

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK1349572, Raltegravir, GSK1349572 Placebo)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • GSK1349572
  • +3 more
  • Birmingham, Alabama
  • +180 more
Mar 14, 2022

Healthy Subjects, Hepatic Impairment, Infection, Human Immunodeficiency Virus Trial in Minneapolis (GSK1349572)

Completed
  • Healthy Subjects
  • +3 more
  • GSK1349572
  • Minneapolis, Minnesota
    GSK Investigational Site
Jul 29, 2019

Infection, Human Immunodeficiency Virus, HIV Trial in Austin (GSK1349572)

Completed
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • GSK1349572
  • Austin, Texas
    GSK Investigational Site
Jun 20, 2019

Infection, Human Immunodeficiency Virus Trial in Worldwide (GSK1349572, efavirenz)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • Phoenix, Arizona
  • +34 more
Dec 14, 2017

Infections, Human Immunodeficiency Virus and Herpesviridae Trial in Buffalo (GSK1349572, Efavirenz)

Completed
  • Infections, Human Immunodeficiency Virus and Herpesviridae
  • Buffalo, New York
    GSK Investigational Site
Sep 21, 2017

Infection, Human Immunodeficiency Virus Trial in Baltimore (GSK1349572, Rifampin, Rifabutin)

Completed
  • Infection, Human Immunodeficiency Virus
  • GSK1349572
  • +2 more
  • Baltimore, Maryland
    GSK Investigational Site
Jun 6, 2017

Healthy Subjects Trial in Madison (GSK1349572)

Completed
  • Healthy Subjects
  • GSK1349572
  • Madison, Wisconsin
    GSK Investigational Site
Feb 1, 2017

Infections, Human Immunodeficiency Virus and Herpesviridae Trial in Buffalo (GSK1349572, Fosamprenavir, Ritonavir)

Completed
  • Infections, Human Immunodeficiency Virus and Herpesviridae
  • GSK1349572
  • +2 more
  • Buffalo, New York
    GSK Investigational Site
Jan 17, 2017

Infection, Human Immunodeficiency Virus I Trial in Buffalo (GSK1349572, GSK2248761)

Withdrawn
  • Infection, Human Immunodeficiency Virus I
  • Buffalo, New York
    GSK Investigational Site
Dec 22, 2014

Infection, Human Immunodeficiency Virus Trial in United States (GSK1349572, Placebo)

Completed
Has Results
  • Infection, Human Immunodeficiency Virus
  • GSK1349572
  • Placebo
  • Bakersfield, California
  • +17 more
Nov 7, 2013

Infections, Human Immunodeficiency Virus and Tuberculosis Trial in Minneapolis (GSK1349572, Placebo, Iohexol Injection)

Completed
  • Infections, Human Immunodeficiency Virus and Tuberculosis
  • GSK1349572
  • +3 more
  • Minneapolis, Minnesota
    GSK Investigational Site
Jun 7, 2012

Healthy Volunteer Trial in Buffalo (Darunavir, Etravirine, Ritonavir)

Completed
  • Healthy Volunteer
  • Buffalo, New York
    GSK Investigational Site
Feb 20, 2012

Infection, Human Immunodeficiency Virus Trial in Cypress (GSK1349572)

Completed
  • Infection, Human Immunodeficiency Virus
  • GSK1349572
  • Cypress, California
    GSK Investigational Site
Jun 23, 2011

Healthy Subjects Trial in Evansville (GSK1349572)

Completed
  • Healthy Subjects
  • GSK1349572
  • Evansville, Indiana
    GSK Investigational Site
Oct 13, 2010

Healthy Subjects, Infection, Human Immunodeficiency Virus Trial in Buffalo (GSK1349572)

Completed
  • Healthy Subjects
  • Infection, Human Immunodeficiency Virus
  • GSK1349572
  • Buffalo, New York
    GSK Investigational Site
Sep 9, 2010

Healthy Volunteer Trial in Baltimore (GSK1349572, Placebo, Omeprazole)

Completed
  • Healthy Volunteer
  • GSK1349572
  • +2 more
  • Baltimore, Maryland
    GSK Investigational Site
Oct 8, 2009

Healthy Volunteer Trial in Buffalo (GSK1349572 and MaaloxAdvanced Maximum Strength, GSK1349572 and Maalox Advanced Maximum

Completed
  • Healthy Volunteer
  • GSK1349572 and MaaloxAdvanced Maximum Strength
  • +3 more
  • Buffalo, New York
    GSK Investigational Site
Jun 4, 2009

Healthy Volunteer Trial in Austin (GSK1349572, Atazanavir 300 mg, Atazanavir 400 mg)

Completed
  • Healthy Volunteer
  • GSK1349572
  • +3 more
  • Austin, Texas
    GSK Investigational Site
Jun 18, 2009

Healthy Subjects Trial in Buffalo (GSK1349572)

Completed
  • Healthy Subjects
  • GSK1349572
  • Buffalo, New York
    GSK Investigational Site
Jun 4, 2009